Eli Lilly on Tuesday announced a $5 billion investment in a manufacturing facility in Virginia as the pharmaceutical giant looks to expand its domestic production capacity amid the threat of tariffs.

US appeals court in Chicago upholds jury verdict, damages Jury found Lilly didn't rebate Medicaid for higher prices Lilly disagrees with decision, plans appeal Sept 11 (Reuters) - A federal appeals ...

Patients on Eli Lilly & Co.’s experimental diabetes pill lost more weight and had better blood sugar control than those on an older, approved rival from Novo Nordisk A/S in the first head-to-head ...

FDA's new voucher could shorten drug review to 1-2 months Lilly's orforglipron targets high-burden chronic condition Analysts predict price erosion due to new market entrants Sept 16 (Reuters) - Eli ...

Eli Lilly is making waves in the corporate debt market with a $6.75 billion multi-tranche bond sale that includes a rare 40-year note: an unusual move for a pharmaceutical company. Most corporate ...

Eli Lilly's two biggest growth drivers are far from having reached their peak. The company should record significant clinical progress in the next three years. Despite some potential headwinds, the ...

HE’S BEING HELD WITHOUT BAIL TONIGHT, AND THE UNIVERSITY OF LOUISVILLE IS INVESTIGATING POSTERS DEPICTING KIRK’S ASSASSINATION. SOMEONE PUT UP A PICTURES OF KIRK BEING SHOT IN BUILDINGS THROUGHOUT THE ...

The U.S. Food and Drug Administration’s recent enforcement action against drug promotion is sending ETFs with exposure to weight-loss treatment manufacturers into question. Check out the current price ...

Orforglipron outperformed oral semaglutide in reducing A1C and promoting weight loss in type 2 diabetes patients. The trial reinforced Orforglipron's potential as a foundational treatment due to its ...

Takeda Pharmaceutical Co. announced on Thursday that it has recruited longtime Eli Lilly executive Rhonda Pacheco to lead its US business out of Cambridge. It’s a homecoming for Pacheco, a ...

An intriguing new option is coming for weight-loss drugs: a pill that you take once a day to shed pounds, rather than the weekly injections that have powered the anti-obesity revolution up to now. The ...